Central Retinal Enrichment Supplementation Trials (CREST): Design and Methodology of the CREST Randomized Controlled Trials

References

• Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exper Eye Res 1997;64:211–218
   PubMed Web of Science ®Google Scholar
• Snodderly DM, Brown PK, Delori FC, Auran JD. The Macular Pigment.1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984;25:660–673
   PubMed Web of Science ®Google Scholar
• Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 1997;38:1802–1811
   PubMed Web of Science ®Google Scholar
• Sabour-Pickett S, Nolan JM, Loughman J, Beatty S. A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. Mol Nutr Food Res 2012;56:270–286
   PubMed Web of Science ®Google Scholar
• Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003;290:2057–2060
   PubMed Web of Science ®Google Scholar
• Nolan JM, Loughman J, Akkali MC, et al. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vision Res 2011;51:459–469
   PubMed Web of Science ®Google Scholar
• Loughman J, Nolan JM, Howard AN, et al. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci 2012;53:7871–7880
   PubMed Web of Science ®Google Scholar
• Stringham JM, Garcia PV, Smith PA, et al. Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort. Invest Ophthalmol Vis Sci 2011;52:7406–7415
   PubMed Web of Science ®Google Scholar
• Nolan JM, Akkali MC, Loughman J, et al. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Exp Eye Res 2012;101:9–15
   PubMed Web of Science ®Google Scholar
• Meagher KA, Thurnham DI, Beatty S, et al. Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. Br J Nutr 2013;110:289–300
   PubMed Web of Science ®Google Scholar
• Hirsch J, Curcio CA. The spatial resolution capacity of human foveal retina. Vision Res 1989;29:1095–1101
   PubMed Web of Science ®Google Scholar
• Li B, Ahmed F, Bernstein PS. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys 2010;504:56–60
   PubMed Web of Science ®Google Scholar
• Billsten HH, Bhosale P, Yemelyanov A, et al. Photophysical properties of xanthophylls in carotenoproteins from human retinas. Photochem Photobiol 2003;78:138–145
   PubMed Web of Science ®Google Scholar
• Kirby ML, Beatty S, Loane E, et al. A central dip in the macular pigment spatial profile is associated with age and smoking. Invest Ophthalmol Vis Sci 2010;51:6722–6728
   Google Scholar
• Connolly EE, Beatty S, Thurnham DI, et al. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res 2010;35:335–351
   PubMed Web of Science ®Google Scholar
• Charalampidou S, Loughman J, Nolan J, et al. Prognostic indicators and outcome measures for surgical removal of symptomatic nonadvanced cataract. Arch Ophthalmol 2011;129:1155–1161
   Google Scholar
• Neelam K, Nolan J, Chakravarthy U, Beatty S. Psychophysical function in age-related maculopathy. Surv Ophthalmol 2009;54:167–210
   PubMed Web of Science ®Google Scholar
• Beatty S, Chakravarthy U, Nolan JM, et al. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology 2013;120:600–606
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials 2010;11:32
   PubMed Web of Science ®Google Scholar
• Friedman LM, Furberg CD, Demets DL. Fundamentals of clinical trials. 4th ed. New York: Springer; 2010
   Google Scholar
• Kramer CFL, Theimann J. How many subjects?: Statistical power analysis in research. Thousand Oaks, CA: Sage Publications; 1987
   Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988
   Google Scholar
• Hintze J. PASS 2008. In: NCSS LLC. Kaysville, Utah; 2008
   Google Scholar
• Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 2005;123:1484–1498
   PubMed Web of Science ®Google Scholar
• Feinman RD. Intention-to-treat. What is the question? Nutr Metab (Lond) 2009;6:1
   PubMedGoogle Scholar
• Gupta SK. Intention-to-treat concept: a review. Perspect Clin Res 2011;2:109–112
   PubMedGoogle Scholar
• Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol 1992;21:837–841
   PubMed Web of Science ®Google Scholar
• Orr P, Rentz AM, Margolis MK, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci 2011;52:3354–3359
   PubMed Web of Science ®Google Scholar
• Revicki DA, Rentz AM, Harnam N, et al. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 2010;51:712–717
   PubMedGoogle Scholar
• Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050–1058
   PubMed Web of Science ®Google Scholar
• Meagher KA, Thurnham DI, Beatty S, et al. Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. Br J Nutr 2013;110:289–300
   PubMed Web of Science ®Google Scholar
• Lawrence AD, Sahakian BJ. The neuropsychology of frontostriatal dementias. In: Woods RT, editor. Handbook of the clinical psychology of aging. New York: Wiley; 1996:243–265
   Google Scholar
• Robbins TW, James M, Owen AM, et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994;5:266–281
   PubMedGoogle Scholar
• Wild K, Howieson D, Webbe F, et al. Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement 2008;4:428–437
   PubMed Web of Science ®Google Scholar
• Lawrence AD, Sahakian BJ, Hodges JR, et al. Executive and mnemonic functions in early Huntington’s disease. Brain 1996;119:1633–1645
   PubMed Web of Science ®Google Scholar
• Owen AM, Downes JJ, Sahakian BJ, et al. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 1990;28:1021–1034
   PubMed Web of Science ®Google Scholar
• Fried R, Hirshfeld-Becker D, Petty C, et al. How informative is the CANTAB to assess executive functioning in children with ADHD? A controlled study. J Atten Disord 2012, Aug 24 (Epub ahead of print)
   Google Scholar
• Sahakian BJ, Downes JJ, Eagger S, et al. Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type. Neuropsychologia 1990;28:1197–1213
   PubMed Web of Science ®Google Scholar
• Robbins TW, James M, Owen AM, et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994;5:266–281
   PubMedGoogle Scholar
• Sweeney JA, Kmiec JA, Kupfer DJ. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 2000;48:674–684
   PubMed Web of Science ®Google Scholar
• Cognition Limited. CANTAB Eclipse Test Administration Guide. Cambridge, UK: Cambridge Cognition Limited; 2012
   Google Scholar
• Charalampidou S, Nolan J, Loughman J, et al. Psychophysical impact and optical and morphological characteristics of symptomatic non-advanced cataract. Eye (Lond) 2011;25:1147–1154
   Google Scholar
• Hohberger B, Laemmer R, Adler W, et al. Measuring contrast sensitivity in normal subjects with OPTEC 6500: influence of age and glare. Graefes Arch Clin Exp Ophthalmol 2007;245:1805–1814
   PubMed Web of Science ®Google Scholar
• Hitchcock EM, Dick RB, Krieg EF. Visual contrast sensitivity testing: a comparison of two F.A.C.T. test types. Neurotoxicol Teratol 2004;26:271–277
   PubMed Web of Science ®Google Scholar
• Terzi E, Buhren J, Wesemann W, Kohnen T. [Frankfurt-Freiburg Contrast and Acuity Test System (FF-CATS). A new test to determine contrast sensitivity under variable ambient and glare luminance levels]. Ophthalmologe 2005;102:507–513
   Google Scholar
• Loughman J, Akkali MC, Beatty S, et al. The relationship between macular pigment and visual performance. Vision Res 2010;50:1249–1256
   PubMed Web of Science ®Google Scholar
• van Gaalen KW, Jansonius NM, Koopmans SA, et al. Relationship between contrast sensitivity and spherical aberration: comparison of 7 contrast sensitivity tests with natural and artificial pupils in healthy eyes. J Cataract Refract Surg 2009;35:47–56
   Google Scholar
• Coppens JE, Franssen L, Van Rijn LJ, van den Berg TJ. Reliability of the compensation comparison stray-light measurement method. J Biomed Opt 2006;11:34027
   Web of Science ®Google Scholar
• Franssen L, Coppens JE, van den Berg TJ. Compensation comparison method for assessment of retinal straylight. Invest Ophthalmol Vis Sci 2006;47:768–776
   PubMed Web of Science ®Google Scholar
• van den Berg TJ, Van Rijn LJ, Michael R, et al. Straylight effects with aging and lens extraction. Am J Ophthalmol 2007;144:358–363
   PubMed Web of Science ®Google Scholar
• Wooten BR, Hammond BR. Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry. Optometry Vis Sci 2005;82:378–386
   PubMed Web of Science ®Google Scholar
• Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999;40:2481–2489
   PubMed Web of Science ®Google Scholar
• Stringham JM, Hammond BR, Nolan JM, et al. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res 2008;87:445–453
   PubMed Web of Science ®Google Scholar
• Loane E, Stack J, Beatty S, Nolan JM. Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr Eye Res 2007;32:555–564
   PubMed Web of Science ®Google Scholar
• Delori FC, Goger DG, Hammond BR, et al. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Optical Soc Am A-Optics Image Sci Vis 2001;18:1212–1230
   PubMed Web of Science ®Google Scholar
• Wustemeyer H, Jahn C, Nestler A, et al. A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 2002;240:666–671
   PubMed Web of Science ®Google Scholar
• Trieschmann M, Heimes B, Hense H, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol 2006;244:1565–1574
   Web of Science ®Google Scholar
• Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 2009;50:3432–3437
   PubMed Web of Science ®Google Scholar
• Stifter E, Konig F, Lang T, et al. Reliability of a standardized reading chart system: variance component analysis, test-retest and inter-chart reliability. Graefes Arch Clin Exp Ophthalmol 2004;242:31–39
   Web of Science ®Google Scholar
• Beatty S, Koh HH, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115–134
   PubMed Web of Science ®Google Scholar
• Kassoff A, Kassoff J, Buehler J, et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss – AREDS Report No. 8. Arch Ophthalmol 2001;119:1417–1436
   PubMedGoogle Scholar
• Chew EY, Clemons TE, SanGiovanni JP, et al. Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS2 Report No. 3. JAMA Ophthalmol 2013
   Google Scholar
• Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005–2015
   Google Scholar
• Neelam K, Hogg RE, Stevenson MR, et al. Carotenoids and co-antioxidants in age-related maculopathy: design and methods. Ophthalmic Epidemiol 2008;15:389–401
   PubMed Web of Science ®Google Scholar
• Beatty S, Nolan JM, Muldrew KA, et al. Visual outcome after antioxidant supplementation. Ophthalmology 2013;120:645
   Google Scholar
• Vishwanathan R, Neuringer M, Snodderly DM, et al. Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr Neurosci 2013;16:21–29
   PubMed Web of Science ®Google Scholar
• Rafnsson SB, Dilis V, Trichopoulou A. Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies. Eur J Nutr 2013;52:1553–1567
   PubMed Web of Science ®Google Scholar
• Gray SL, Hanlon JT, Landerman LR, et al. Is antioxidant use protective of cognitive function in the community-dwelling elderly? Am J Geriatr Pharmacother 2003;1:3–10
   PubMedGoogle Scholar
• Salerno-Kennedy R, Cashman KD. Relationship between dementia and nutrition-related factors and disorders: an overview. Int J Vitam Nutr Res 2005;75:83–95
   PubMed Web of Science ®Google Scholar